- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Biologics & Biosimilars market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Biologics & Biosimilars market. Detailed analysis of key players, along with key growth strategies adopted by Biologics & Biosimilars industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Amgen
Roche
AbbVie
Novartis
Lilly
Hospira
Changchun High Tech
Sanofi
Mylan
CP Guojian Pharmacy
Biotech Pharma
Novo Nordisk
Gelgen Biopharma
fizer
3sbio
Johnson & Johnson
Merck
Teva
Sandoz
By Type:
Antibiotic
Enzyme
Hormone
Non-Patented Biological Reagents
Other
By End-User:
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Biologics & Biosimilars Market
-
1.3 Market Segment by Type
-
1.3.1 USA Biologics & Biosimilars Market Size and Growth Rate of Antibiotic from 2016 to 2027
-
1.3.2 USA Biologics & Biosimilars Market Size and Growth Rate of Enzyme from 2016 to 2027
-
1.3.3 USA Biologics & Biosimilars Market Size and Growth Rate of Hormone from 2016 to 2027
-
1.3.4 USA Biologics & Biosimilars Market Size and Growth Rate of Non-Patented Biological Reagents from 2016 to 2027
-
1.3.5 USA Biologics & Biosimilars Market Size and Growth Rate of Other from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Biologics & Biosimilars Market Size and Growth Rate of Tumor from 2016 to 2027
-
1.4.2 USA Biologics & Biosimilars Market Size and Growth Rate of Diabetes from 2016 to 2027
-
1.4.3 USA Biologics & Biosimilars Market Size and Growth Rate of Cardiovascular from 2016 to 2027
-
1.4.4 USA Biologics & Biosimilars Market Size and Growth Rate of Hemophilia from 2016 to 2027
-
1.4.5 USA Biologics & Biosimilars Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Biologics & Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Biologics & Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Biologics & Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Biologics & Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Biologics & Biosimilars Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Biologics & Biosimilars by Major Types
-
3.4.1 Market Size and Growth Rate of Antibiotic
-
3.4.2 Market Size and Growth Rate of Enzyme
-
3.4.3 Market Size and Growth Rate of Hormone
-
3.4.4 Market Size and Growth Rate of Non-Patented Biological Reagents
-
3.4.5 Market Size and Growth Rate of Other
4 Segmentation of Biologics & Biosimilars Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Biologics & Biosimilars by Major End-Users
-
4.4.1 Market Size and Growth Rate of Biologics & Biosimilars in Tumor
-
4.4.2 Market Size and Growth Rate of Biologics & Biosimilars in Diabetes
-
4.4.3 Market Size and Growth Rate of Biologics & Biosimilars in Cardiovascular
-
4.4.4 Market Size and Growth Rate of Biologics & Biosimilars in Hemophilia
-
4.4.5 Market Size and Growth Rate of Biologics & Biosimilars in Other
5 Market Analysis by Regions
-
5.1 USA Biologics & Biosimilars Production Analysis by Regions
-
5.2 USA Biologics & Biosimilars Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Biologics & Biosimilars Landscape Analysis
-
6.1 West USA Biologics & Biosimilars Landscape Analysis by Major Types
-
6.2 West USA Biologics & Biosimilars Landscape Analysis by Major End-Users
7 South USA Biologics & Biosimilars Landscape Analysis
-
7.1 South USA Biologics & Biosimilars Landscape Analysis by Major Types
-
7.2 South USA Biologics & Biosimilars Landscape Analysis by Major End-Users
8 Middle West USA Biologics & Biosimilars Landscape Analysis
-
8.1 Middle West USA Biologics & Biosimilars Landscape Analysis by Major Types
-
8.2 Middle West USA Biologics & Biosimilars Landscape Analysis by Major End-Users
9 Northeast USA Biologics & Biosimilars Landscape Analysis
-
9.1 Northeast USA Biologics & Biosimilars Landscape Analysis by Major Types
-
9.2 Northeast USA Biologics & Biosimilars Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Amgen
-
10.1.1 Amgen Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Roche
-
10.2.1 Roche Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 AbbVie
-
10.3.1 AbbVie Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Novartis
-
10.4.1 Novartis Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Lilly
-
10.5.1 Lilly Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Hospira
-
10.6.1 Hospira Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Changchun High Tech
-
10.7.1 Changchun High Tech Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Sanofi
-
10.8.1 Sanofi Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Mylan
-
10.9.1 Mylan Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 CP Guojian Pharmacy
-
10.10.1 CP Guojian Pharmacy Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Biotech Pharma
-
10.11.1 Biotech Pharma Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Novo Nordisk
-
10.12.1 Novo Nordisk Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 Gelgen Biopharma
-
10.13.1 Gelgen Biopharma Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
-
10.14 fizer
-
10.14.1 fizer Company Profile and Recent Development
-
10.14.2 Market Performance
-
10.14.3 Product and Service Introduction
-
10.15 3sbio
-
10.15.1 3sbio Company Profile and Recent Development
-
10.15.2 Market Performance
-
10.15.3 Product and Service Introduction
-
10.16 Johnson & Johnson
-
10.16.1 Johnson & Johnson Company Profile and Recent Development
-
10.16.2 Market Performance
-
10.16.3 Product and Service Introduction
-
10.17 Merck
-
10.17.1 Merck Company Profile and Recent Development
-
10.17.2 Market Performance
-
10.17.3 Product and Service Introduction
-
10.18 Teva
-
10.18.1 Teva Company Profile and Recent Development
-
10.18.2 Market Performance
-
10.18.3 Product and Service Introduction
-
10.19 Sandoz
-
10.19.1 Sandoz Company Profile and Recent Development
-
10.19.2 Market Performance
-
10.19.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Biologics & Biosimilars Market Size and Growth Rate of Antibiotic from 2016 to 2027
-
Figure USA Biologics & Biosimilars Market Size and Growth Rate of Enzyme from 2016 to 2027
-
Figure USA Biologics & Biosimilars Market Size and Growth Rate of Hormone from 2016 to 2027
-
Figure USA Biologics & Biosimilars Market Size and Growth Rate of Non-Patented Biological Reagents from 2016 to 2027
-
Figure USA Biologics & Biosimilars Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Biologics & Biosimilars Market Size and Growth Rate of Tumor from 2016 to 2027
-
Figure USA Biologics & Biosimilars Market Size and Growth Rate of Diabetes from 2016 to 2027
-
Figure USA Biologics & Biosimilars Market Size and Growth Rate of Cardiovascular from 2016 to 2027
-
Figure USA Biologics & Biosimilars Market Size and Growth Rate of Hemophilia from 2016 to 2027
-
Figure USA Biologics & Biosimilars Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Biologics & Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Biologics & Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Biologics & Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Biologics & Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Biologics & Biosimilars Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Biologics & Biosimilars
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Biologics & Biosimilars by Different Types from 2016 to 2027
-
Table Consumption Share of Biologics & Biosimilars by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Antibiotic
-
Figure Market Size and Growth Rate of Enzyme
-
Figure Market Size and Growth Rate of Hormone
-
Figure Market Size and Growth Rate of Non-Patented Biological Reagents
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Biologics & Biosimilars by Different End-Users from 2016 to 2027
-
Table Consumption Share of Biologics & Biosimilars by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Tumor
-
Figure Market Size and Growth Rate of Diabetes
-
Figure Market Size and Growth Rate of Cardiovascular
-
Figure Market Size and Growth Rate of Hemophilia
-
Figure Market Size and Growth Rate of Other
-
Table USA Biologics & Biosimilars Production by Regions
-
Table USA Biologics & Biosimilars Production Share by Regions
-
Figure USA Biologics & Biosimilars Production Share by Regions in 2016
-
Figure USA Biologics & Biosimilars Production Share by Regions in 2021
-
Figure USA Biologics & Biosimilars Production Share by Regions in 2027
-
Table USA Biologics & Biosimilars Consumption by Regions
-
Table USA Biologics & Biosimilars Consumption Share by Regions
-
Figure USA Biologics & Biosimilars Consumption Share by Regions in 2016
-
Figure USA Biologics & Biosimilars Consumption Share by Regions in 2021
-
Figure USA Biologics & Biosimilars Consumption Share by Regions in 2027
-
Table West USA Biologics & Biosimilars Consumption by Types from 2016 to 2027
-
Table West USA Biologics & Biosimilars Consumption Share by Types from 2016 to 2027
-
Figure West USA Biologics & Biosimilars Consumption Share by Types in 2016
-
Figure West USA Biologics & Biosimilars Consumption Share by Types in 2021
-
Figure West USA Biologics & Biosimilars Consumption Share by Types in 2027
-
Table West USA Biologics & Biosimilars Consumption by End-Users from 2016 to 2027
-
Table West USA Biologics & Biosimilars Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Biologics & Biosimilars Consumption Share by End-Users in 2016
-
Figure West USA Biologics & Biosimilars Consumption Share by End-Users in 2021
-
Figure West USA Biologics & Biosimilars Consumption Share by End-Users in 2027
-
Table South USA Biologics & Biosimilars Consumption by Types from 2016 to 2027
-
Table South USA Biologics & Biosimilars Consumption Share by Types from 2016 to 2027
-
Figure South USA Biologics & Biosimilars Consumption Share by Types in 2016
-
Figure South USA Biologics & Biosimilars Consumption Share by Types in 2021
-
Figure South USA Biologics & Biosimilars Consumption Share by Types in 2027
-
Table South USA Biologics & Biosimilars Consumption by End-Users from 2016 to 2027
-
Table South USA Biologics & Biosimilars Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Biologics & Biosimilars Consumption Share by End-Users in 2016
-
Figure South USA Biologics & Biosimilars Consumption Share by End-Users in 2021
-
Figure South USA Biologics & Biosimilars Consumption Share by End-Users in 2027
-
Table Middle West USA Biologics & Biosimilars Consumption by Types from 2016 to 2027
-
Table Middle West USA Biologics & Biosimilars Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Biologics & Biosimilars Consumption Share by Types in 2016
-
Figure Middle West USA Biologics & Biosimilars Consumption Share by Types in 2021
-
Figure Middle West USA Biologics & Biosimilars Consumption Share by Types in 2027
-
Table Middle West USA Biologics & Biosimilars Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Biologics & Biosimilars Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Biologics & Biosimilars Consumption Share by End-Users in 2016
-
Figure Middle West USA Biologics & Biosimilars Consumption Share by End-Users in 2021
-
Figure Middle West USA Biologics & Biosimilars Consumption Share by End-Users in 2027
-
Table Northeast USA Biologics & Biosimilars Consumption by Types from 2016 to 2027
-
Table Northeast USA Biologics & Biosimilars Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Biologics & Biosimilars Consumption Share by Types in 2016
-
Figure Northeast USA Biologics & Biosimilars Consumption Share by Types in 2021
-
Figure Northeast USA Biologics & Biosimilars Consumption Share by Types in 2027
-
Table Northeast USA Biologics & Biosimilars Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Biologics & Biosimilars Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Biologics & Biosimilars Consumption Share by End-Users in 2016
-
Figure Northeast USA Biologics & Biosimilars Consumption Share by End-Users in 2021
-
Figure Northeast USA Biologics & Biosimilars Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lilly
-
Figure Sales and Growth Rate Analysis of Lilly
-
Figure Revenue and Market Share Analysis of Lilly
-
Table Product and Service Introduction of Lilly
-
Table Company Profile and Development Status of Hospira
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira
-
Figure Sales and Growth Rate Analysis of Hospira
-
Figure Revenue and Market Share Analysis of Hospira
-
Table Product and Service Introduction of Hospira
-
Table Company Profile and Development Status of Changchun High Tech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Changchun High Tech
-
Figure Sales and Growth Rate Analysis of Changchun High Tech
-
Figure Revenue and Market Share Analysis of Changchun High Tech
-
Table Product and Service Introduction of Changchun High Tech
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Mylan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
-
Figure Sales and Growth Rate Analysis of Mylan
-
Figure Revenue and Market Share Analysis of Mylan
-
Table Product and Service Introduction of Mylan
-
Table Company Profile and Development Status of CP Guojian Pharmacy
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CP Guojian Pharmacy
-
Figure Sales and Growth Rate Analysis of CP Guojian Pharmacy
-
Figure Revenue and Market Share Analysis of CP Guojian Pharmacy
-
Table Product and Service Introduction of CP Guojian Pharmacy
-
Table Company Profile and Development Status of Biotech Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotech Pharma
-
Figure Sales and Growth Rate Analysis of Biotech Pharma
-
Figure Revenue and Market Share Analysis of Biotech Pharma
-
Table Product and Service Introduction of Biotech Pharma
-
Table Company Profile and Development Status of Novo Nordisk
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk
-
Figure Sales and Growth Rate Analysis of Novo Nordisk
-
Figure Revenue and Market Share Analysis of Novo Nordisk
-
Table Product and Service Introduction of Novo Nordisk
-
Table Company Profile and Development Status of Gelgen Biopharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gelgen Biopharma
-
Figure Sales and Growth Rate Analysis of Gelgen Biopharma
-
Figure Revenue and Market Share Analysis of Gelgen Biopharma
-
Table Product and Service Introduction of Gelgen Biopharma
-
Table Company Profile and Development Status of fizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of fizer
-
Figure Sales and Growth Rate Analysis of fizer
-
Figure Revenue and Market Share Analysis of fizer
-
Table Product and Service Introduction of fizer
-
Table Company Profile and Development Status of 3sbio
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of 3sbio
-
Figure Sales and Growth Rate Analysis of 3sbio
-
Figure Revenue and Market Share Analysis of 3sbio
-
Table Product and Service Introduction of 3sbio
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Teva
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva
-
Figure Sales and Growth Rate Analysis of Teva
-
Figure Revenue and Market Share Analysis of Teva
-
Table Product and Service Introduction of Teva
-
Table Company Profile and Development Status of Sandoz
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz
-
Figure Sales and Growth Rate Analysis of Sandoz
-
Figure Revenue and Market Share Analysis of Sandoz
-
Table Product and Service Introduction of Sandoz
-